Cargando…
Editorial: Design, Synthesis, and Preclinical Testing of Innovative Anti-Cancer Compounds With a High Level of Selectivity of Action and Low Toxicity
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9021606/ https://www.ncbi.nlm.nih.gov/pubmed/35463962 http://dx.doi.org/10.3389/fmolb.2022.859821 |
| _version_ | 1784689871359574016 |
|---|---|
| author | Ferreira, Ana Maria Da Costa Schneider-Stock, Regine Aiello, Francesca |
| author_facet | Ferreira, Ana Maria Da Costa Schneider-Stock, Regine Aiello, Francesca |
| author_sort | Ferreira, Ana Maria Da Costa |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9021606 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Frontiers Media S.A. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-90216062022-04-22 Editorial: Design, Synthesis, and Preclinical Testing of Innovative Anti-Cancer Compounds With a High Level of Selectivity of Action and Low Toxicity Ferreira, Ana Maria Da Costa Schneider-Stock, Regine Aiello, Francesca Front Mol Biosci Molecular Biosciences Frontiers Media S.A. 2022-04-07 /pmc/articles/PMC9021606/ /pubmed/35463962 http://dx.doi.org/10.3389/fmolb.2022.859821 Text en Copyright © 2022 Ferreira, Schneider-Stock and Aiello. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
| spellingShingle | Molecular Biosciences Ferreira, Ana Maria Da Costa Schneider-Stock, Regine Aiello, Francesca Editorial: Design, Synthesis, and Preclinical Testing of Innovative Anti-Cancer Compounds With a High Level of Selectivity of Action and Low Toxicity |
| title | Editorial: Design, Synthesis, and Preclinical Testing of Innovative Anti-Cancer Compounds With a High Level of Selectivity of Action and Low Toxicity |
| title_full | Editorial: Design, Synthesis, and Preclinical Testing of Innovative Anti-Cancer Compounds With a High Level of Selectivity of Action and Low Toxicity |
| title_fullStr | Editorial: Design, Synthesis, and Preclinical Testing of Innovative Anti-Cancer Compounds With a High Level of Selectivity of Action and Low Toxicity |
| title_full_unstemmed | Editorial: Design, Synthesis, and Preclinical Testing of Innovative Anti-Cancer Compounds With a High Level of Selectivity of Action and Low Toxicity |
| title_short | Editorial: Design, Synthesis, and Preclinical Testing of Innovative Anti-Cancer Compounds With a High Level of Selectivity of Action and Low Toxicity |
| title_sort | editorial: design, synthesis, and preclinical testing of innovative anti-cancer compounds with a high level of selectivity of action and low toxicity |
| topic | Molecular Biosciences |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9021606/ https://www.ncbi.nlm.nih.gov/pubmed/35463962 http://dx.doi.org/10.3389/fmolb.2022.859821 |
| work_keys_str_mv | AT ferreiraanamariadacosta editorialdesignsynthesisandpreclinicaltestingofinnovativeanticancercompoundswithahighlevelofselectivityofactionandlowtoxicity AT schneiderstockregine editorialdesignsynthesisandpreclinicaltestingofinnovativeanticancercompoundswithahighlevelofselectivityofactionandlowtoxicity AT aiellofrancesca editorialdesignsynthesisandpreclinicaltestingofinnovativeanticancercompoundswithahighlevelofselectivityofactionandlowtoxicity |